A distinct role of RhoB in gastric cancer suppression

International Journal of Cancer

Volumn 128, Issue 5, 2011, Pages 1057-1068

  Zhou, Jitao ^a   Zhu, Yajie ^a   Zhang, Guoyun ^a   Liu, Na ^a   Sun, Lijun ^a   Liu, Ming ^a   Qiu, Meng ^a   Luo, Deyun ^a   Tang, Qiulin ^a   Liao, Zhengyin ^a   Zheng, Yi ^b   Bi, Feng ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

gastric cancer; Rho GTPases; RhoB; signaling; tumor suppressor

Indexed keywords

COMPLEMENTARY DNA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; RHOB GTP-BINDING PROTEIN; STOMACH NEOPLASMS;

EID: 78650746714     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25445     Document Type: Article

References (49)

1. Sahai E, Marshall CJ,. Rho-GTPases and cancer. Nat Rev Cancer 2002; 2: 133-42.
2. Aznar S, Lacal JC,. Searching new targets for anticancer drug design: the families of Ras and RhoGTPases and their effectors. Prog Nucleic Acid Res Mol Biol 2001; 67: 193-234.
3. Bar-Sagi D, Hall A,. Ras and Rho GTPases: a family reunion. Cell 2000; 103: 227-38.
4. Schmitz AAP, Govek EE, Bottner B, Van Aelst L,. Rho GTPases: signaling, migration and invasion. Exp Cell Res 2000; 261: 1-12.
5. Fritz G, Just I, Kaina B,. Rho GTPases are over-expressed in human tumors. Int J Cancer 1998; 819: 682-7.
6. Kamai T, Arai K, Tsujii T, Honda M, Yoshida K,. Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumor. BJU Int 2001; 87: 227-31.
7. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H,. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003; 9: 2632-41.
8. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, Konishi I,. Up-regulation of small GTPases Rho A and Rho C, is associated with tumor progression in ovarian carcinoma. Lab Invest 2003; 83: 861-70.
9. Abraham MT, Kuriakose MA, Sacks PG, Yee H, Chiriboga L, Bearer EL, Delacure MD,. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 2001; 111: 1285-9.
10. Boone B, Van Gele M, Lambert J, Haspeslagh M, Brochez L,. The role of RhoC in growth and metastatic capacity of melanoma. J Cutan Pathol 2009; 36: 629-36.
11. Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, Tillement V, Pradines A, Sebti S, Favre G,. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 2004; 10: 2742-50.
12. Adnane J, Muro-Cacho C, Mathews L, Sebti SM, Munoz-Antonia T,. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. Clin Cancer Res 2002; 8: 2225-32.
13. Sato N, Fukui T, Taniguchi T, Yokoyama T, Kondo M, Nagasaka T, Goto Y, Gao W, Ueda Y, Yokoi K, Minna JD, Osada H, et al. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int J Cancer 2007; 120: 543-51.
14. Liu AX, Rane N, Liu JP, Prendergast GC,. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol Cell Biol 2001; 21: 6906-12.
15. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B,. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 2002; 87: 635-44.
16. Adamson P, Marshall CJ, Hall A, Tilbrook PA,. Post-translational modifications of p21 rho proteins. J Biol Chem 1992; 267: 20033-8.
17. Gampel A, Parker PJ, Mellor H,. Regulation of epidermal growth factor receptor traffic by the small GTPase rhoB. J Curr Biol 1999; 9: 955-8.
18. Jahner D, Hunter T,. The ras-related gene rho. B is an immediate early gene inducible by v-Ras, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts. Mol Cell Biol 1991; 11: 3682-90.
19. Engel ME, Datta PK, Moses HL,. RhoB is stabilized by transforming growth factor B and antagonizes transcriptional activation. J Biol Chem 1998; 273: 9921-26.
20. Fritz G, Kaina B, Aktories K,. The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J Biol Chem 1995; 270: 25172-7.
21. Roder DM,. The epidemiology of gastric cancer. Gastric Cancer 2002; 5: 5-11.
22. Correa P,. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-40.
23. Liu N, Bi F, Pan Y, Sun L, Xue Y, Shi Y, Yao X, Zheng Y, Fan D,. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 2004; 10: 6239-47.
24. Liu N, Zhang G, Bi F, Pan Y, Xue Y, Shi Y, Yao L, Zhao L, Zheng Y, Fan D,. RhoC is essential for the metastasis of gastric cancer. J Mol Med 2007; 85: 1149-1156.
25. Maaser K, Däubler P, Barthel B, Heine B, von Lampe B, Stein H, Hoffmeister B, Scherer H, Scherübl H,. Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis. Br J Cancer 2003; 88: 1217-22.
26. Guo Y, Xie J, Rubin E, Tang YX, Lin F, Zi X, Hoang BH,. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling. Cancer Res 2008; 68: 3350-60.
27. Wu J, Xia HH, Tu SP, Fan DM, Lin MC, Kung HF, Lam SK, Wong BC,. 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 2003; 24: 243-7.
28. Bacsà Z, Everson RB, Eliason JF,. The DNA of annexin V-binding apoptotic cells is highly fragmented. Cancer Res 2000; 60: 4623-28.
29. Vassena L, Proschan M, Fauci AS, Lusso P,. Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals. PNAS 2007; 104: 2355-60.
30. Karnoub AE, Symons M, Campbell SL, Der CJ,. Molecular basis for Rho GTPase signaling specificity. Breast Cancer Res Treat 2004; 84: 61-71.
31. Tovar D, Faye JC, Favre G,. Cloning of the human RHOB gene promoter: characterization of a VNTR sequence that affects transcriptional activity. Genomics 2003; 81: 525-30.
32. Wang S, Yan-Neale Y, Fischer D, Zeremski M, Cai R, Zhu J, Asselbergs F, Hampton G, Cohen D,. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene 2003; 22: 6204-13.
33. Delarue FL, Adnane J, Joshi B, Blaskovich MA, Wang DA, Hawker J, Bizouarn F, Ohkanda J, Zhu K, Hamilton AD, Chellappan S, Sebti SM,. Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation. HAT association and histone acetylation of the Rho B promoter. Oncogene 2007; 26: 633-40.
34. Jiang K, Delarue FL, Sebti SM,. EGFR. Erb B2 and Ras but not Src suppress Rho B expression while ectopic expression of Rho B antagonizes oncogene-mediated transformation. Oncogene 2004; 23: 1136-45.
35. Adini I, Rabinovitz I, Sun JF, Prendergast GC, Benjamin LE,. RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev 2003; 17: 2721-32.
36. Jiang K, Sun J, Cheng J, Djeu JY, Wei S, Sebti S,. Akt mediates Ras downregulation of RhoB, a suppressor of transformation invasion, and metastasis. Mol Cell Biol 2004; 24: 5565-76.
37. Chen Z, Sun J, Pradines A, Favre G, Adnane J, Sebti SM,. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J Biol Chem 2000; 275: 17974-8.
38. Huang M, Kamasani U, Prendergast GC,. RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3. Oncogene 2006; 25: 1281-89.
39. Fritz G, Kaina B,. Ras-related GTPase Rhob represses NF-kappaB signaling. J Biol Chem 2001; 276: 3115-22.
40. Chen YX, Li ZB, Diao F, Cao DM, Fu CC, Lu J,. Up-regulation of RhoB by glucocorticoids and its effects on the cell proliferation and NF-kappaB transcriptional activity. J Steroid Biochem Mol Biol 2006; 101: 179-187.
41. Rodriquez PL, Sahav S, Olabisi OO, Whitehead IP,. ROCKI-mediated activiation of NF-kappaB by RhoB. Cell Signal 2007; 19: 2361-9.
42. Skuli N, Monferran S, Delmas C, Lajoie-Mazenc I, Favre G, Toulas C, Cohen-Jonathan-Moyal E,. Activation of RhoB by hypoxia controls hypoxia-inducible factor-1α stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells. Cancer Res 2006; 66: 482-9.
43. Ax L, Cerniglia GJ, Bernhard EJ, Prendergast GC,. RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage. Proc Natl Acad Sci USA 2001; 98: 6192-7.
44. Du W, Prendergast GC,. Geranylgeranylated RhoB mediates inhibition of human tumor cell growth by farnesyltransferase inhibitors. Cancer Res 1999; 59: 5924-5928.
45. Kamasani U, Liu AX, Prendergast GC,. Genetic response to farnesyltransferase inhibitors: proapoptotic targets of RhoB. Cancer Biol Ther 2003; 2: 273-80.
46. Liu AX, Du W, Liu JP, Jessell TM, Prendergast GC,. RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors. Mol Cell Biol 2000; 20: 6105-13.
47. Kamasani U, Huang M, Duhadaway JB, Prochownik EV, Donover PS, Prendergast GC,. Cyclin B1 is a critical target of RhoB in the cell suicide program triggered by farnesyl transferase inhibition. Cancer Res 2004; 64: 8389-96.
48. Kong JY, Rabkin SW,. The association between RhoB and caspase-2: changes with lovastatin-induced apoptosis. Biochem Cell Biol 2005; 83: 608-19.
49. Allal C, Pradines A, Hamilton AD, Sebti SM, Favre G,. Farnesylated RhoB prevents cell cycle arrest and actin cytoskeleton disruption caused by the geranylgeranyltransferase I inhibitor GGTI-298. Cell Cycle 2002; 1: 430-7.